OBS! E-bogen kan ikke læses på Kindle eller i iBooks. Du kan læse e-bogen på computer, tablet, smartphone og diverse e-bogslæsere. Du skal bruge et specielt læseprogram til din enhed. Læs mere om programmer, sidetal og print af e-bøger her.
Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are illustrated by cases from Europe, the US, and Asia.
Bog, paperback
Bog, hardback
E-bog, PDF
Vis mereVis mindre
Vis mereVis mindre
Vis mereVis mindre
Hvis denne bog ikke er noget for dig, kan du benytte kategorierne nedenfor til at finde andre titler. Klik på en kategori for at se lignende bøger.